Subject Preference for Scalp Psoriasis Treatment

NCT00438399 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
219
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Galderma R&D